BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32087348)

  • 1. Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12.
    Arab JP; Cabrera D; Sehrawat TS; Jalan-Sakrikar N; Verma VK; Simonetto D; Cao S; Yaqoob U; Leon J; Freire M; Vargas JI; De Assuncao TM; Kwon JH; Guo Y; Kostallari E; Cai Q; Kisseleva T; Oh Y; Arrese M; Huebert RC; Shah VH
    J Hepatol; 2020 Jul; 73(1):149-160. PubMed ID: 32087348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin Pathway.
    Yaqoob U; Luo F; Greuter T; Jalan Sakrikar N; Sehrawat TS; Lu J; Hu X; Gao J; Kostallari E; Chen J; Arab JP; Martin-Mateos R; Cao S; Shah VH
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):545-559. PubMed ID: 32447051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
    Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
    Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells.
    Cao S; Yaqoob U; Das A; Shergill U; Jagavelu K; Huebert RC; Routray C; Abdelmoneim S; Vasdev M; Leof E; Charlton M; Watts RJ; Mukhopadhyay D; Shah VH
    J Clin Invest; 2010 Jul; 120(7):2379-94. PubMed ID: 20577048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression.
    Ramirez T; Li YM; Yin S; Xu MJ; Feng D; Zhou Z; Zang M; Mukhopadhyay P; Varga ZV; Pacher P; Gao B; Wang H
    J Hepatol; 2017 Mar; 66(3):601-609. PubMed ID: 27871879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
    Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
    J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyD88 in hepatic stellate cells promotes the development of alcoholic fatty liver via the AKT pathway.
    Li Y; Wei M; Yuan Q; Liu Y; Tian T; Hou L; Zhang J
    J Mol Med (Berl); 2022 Jul; 100(7):1071-1085. PubMed ID: 35708745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.
    Seth D; Duly A; Kuo PC; McCaughan GW; Haber PS
    World J Gastroenterol; 2014 Sep; 20(36):13088-104. PubMed ID: 25278703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.
    Xu MJ; Cai Y; Wang H; Altamirano J; Chang B; Bertola A; Odena G; Lu J; Tanaka N; Matsusue K; Matsubara T; Mukhopadhyay P; Kimura S; Pacher P; Gonzalez FJ; Bataller R; Gao B
    Gastroenterology; 2015 Oct; 149(4):1030-41.e6. PubMed ID: 26099526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveals distinct roles in fibrogenic injury.
    Newberry EP; Xie Y; Lodeiro C; Solis R; Moritz W; Kennedy S; Barron L; Onufer E; Alpini G; Zhou T; Blaner WS; Chen A; Davidson NO
    FASEB J; 2019 Mar; 33(3):4610-4625. PubMed ID: 30576225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease.
    Chen A; Tang Y; Davis V; Hsu FF; Kennedy SM; Song H; Turk J; Brunt EM; Newberry EP; Davidson NO
    Hepatology; 2013 Jun; 57(6):2202-12. PubMed ID: 23401290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of hepatic stellate cells inhibits hepatic steatosis in mice.
    Kawahara A; Kanno K; Yonezawa S; Otani Y; Kobayashi T; Tazuma S; Ito M
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1946-1954. PubMed ID: 35933582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration.
    Mannaerts I; Schroyen B; Verhulst S; Van Lommel L; Schuit F; Nyssen M; van Grunsven LA
    PLoS One; 2013; 8(12):e84071. PubMed ID: 24358328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.
    Arndt S; Wacker E; Dorn C; Koch A; Saugspier M; Thasler WE; Hartmann A; Bosserhoff AK; Hellerbrand C
    Gut; 2015 Jun; 64(6):973-81. PubMed ID: 25011936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation-dependent galectin-1/neuropilin-1 interactions promote liver fibrosis through activation of TGF-β- and PDGF-like signals in hepatic stellate cells.
    Wu MH; Chen YL; Lee KH; Chang CC; Cheng TM; Wu SY; Tu CC; Tsui WL
    Sci Rep; 2017 Sep; 7(1):11006. PubMed ID: 28887481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
    Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.